We develop innovative new drugs
and are developing world-class pharmaceutical company.
Founded in 1971, we, Sinil Pharmaceutical Co., Ltd have made our fullest efforts to research and spread
outstanding pharmaceutical products over the last 44 years. Since being listed in KOSDAQ in 1999, we have
actively invested in manufacturing facilities and R&D activities to comply with the international standards
We have taken initiatives to develop new natural drugs for the treatment of degenerative arthritis and rheumatoid arthritis to contribute to public health. In 2009, we gained recognition for our new drug development as our new natural drug for osteoarthritis was selected as one of the top 100 Outstanding Outcomes of National R&D Projects.
As these outcomes were achieved with the help of our supportive customers, shareholders, officers, employees, and partners, we would like to express our deep appreciation all your supports.
Sinil Pharmaceutical Co., Ltd has been dedicated to the research and development of higher quality drugs for ‘the Respect of Life and Health’ society. We have always been humbled to contribute to this society.
Today, Sinil Pharmaceutical Co., Ltd is also dedicated to contributing to the public health and the happiness of society developing incrementally modified drugs and new biologicals to treat incurable and rare diseases for the world market.
We will continue to be a global pharmaceutical company expanding its business to the world with active efforts and investment in the development of innovative new drugs developments. We also promise to make our best efforts to give trust to our customers and create new value through management innovations, and grow to be a trusted company with global competitiveness. We would greatly appreciate your interest and encouragement.